|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.103 HKD | 0.00% |
|
+7.29% | -28.47% |
Wai Chun Bio-Technology Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was HKD 405.08 million compared to HKD 287.87 million a year ago. Net loss was HKD 7.83 million compared to HKD 4.47 million a year ago.
Basic loss per share from continuing operations was HKD 0.047 compared to HKD 0.027 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.47% | 2.26M | |
| +16.14% | 29.27B | |
| -21.81% | 3.45B | |
| -20.63% | 566M | |
| -30.70% | 372M | |
| -81.65% | 216M | |
| -9.27% | 117M |
WAI CHUN BIO-TECHNOLOGY LIMITED 
